Should we predict post-operative atrial fibrillation with atrial cardiomyopathy biomarkers?

Int J Cardiol. 2020 May 15:307:71-72. doi: 10.1016/j.ijcard.2020.02.049. Epub 2020 Feb 20.

Authors

Charles Guenancia¹, Audrey Sagnard², Olivier Bouchot³, Luc Lorgis⁴

Affiliations

¹ Dijon Bourgogne University Hospital, Department of Cardiology, Dijon, France; PEC2, EA 7460 Dijon, France. Electronic address: charles.guenancia@chu-dijon.fr.
² Dijon Bourgogne University Hospital, Department of Cardiology, Dijon, France.
³ Dijon Bourgogne University Hospital, Department of Cardiac Surgery, Dijon, France.
⁴ Dijon Bourgogne University Hospital, Department of Cardiology, Dijon, France; PEC2, EA 7460 Dijon, France.

PMID: 32145940
DOI: 10.1016/j.ijcard.2020.02.049

No abstract available

Publication types

Editorial
Comment

MeSH terms

Atrial Fibrillation* / diagnosis
Atrial Fibrillation* / etiology
Atrial Fibrillation* / surgery
Biomarkers
Cardiomyopathies* / diagnosis
Cardiomyopathies* / etiology
Coronary Artery Bypass
Humans
Risk Assessment

Substances

Biomarkers